The risk factors for uveitis among psoriatic arthritis patients: a population-based cohort study.
Nizar HijaziTal GazittAmir HaddadMuna EliasSameer KassemIlan FeldhamerArnon Dov CohenShaul SarOren Tomkins-NetzerWalid SalibaDevy ZismanPublished in: Clinical rheumatology (2023)
PsA is associated with increased risk of uveitis. Past uveitis and treatment with etanercept were associated with higher risk of uveitis. Key Points • Psoriatic arthritis (PsA) is a major risk factor for uveitis with hazard ratio of 2.38 compared to healthy individuals without PsA. • Among PsA patients, the past event of uveitis and treatment with etanercept are risk factors for uveitis. • Uveitis in patients treated with biologics for their PsA requires topical therapy only in most of the cases.
Keyphrases
- juvenile idiopathic arthritis
- ankylosing spondylitis
- prostate cancer
- end stage renal disease
- rheumatoid arthritis
- disease activity
- radical prostatectomy
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- bone marrow
- patient reported outcomes
- rheumatoid arthritis patients
- combination therapy